Product category:
Laboratory and scientific databases
News Release from: Cambridge Cell Networks (CCnet) | Subject: ToxWiz
Edited by the Laboratorytalk Editorial
Team on 24 September 2007
ToxWiz assists compound safety
assessment research
Toxicologists at Surrey will be using CCnet's ToxWiz software for predicting toxic endpoints and for elucidating mechanisms of toxicity in research on drug and chemical safety
ToxWiz contains a network of more than 2500 annotated pathways and clusters linking genomics and proteomics data with biochemical pathways and cellular information It allows users to understand on- and off- target mechanisms of action of compounds, thus minimising the number of animal testing wherever possible
This article was originally published on Laboratorytalk on 22 Jan 2007 at 8.00am (UK)
Related stories
AstraZeneca chooses ToxWiz to predict drug safety
Cambridge Cell Networks (CCnet) reports that ToxWiz is being used by AstraZeneca to predict potential pathological effects of compounds being used to treat diseases and disorders affecting the liver
Massive boost to sample throughput
A new Lims system has helped one of the UK's biggest analytical laboratories to increase its annual sample throughput from 36,000 to 103,000 and to offer a standard five day turnaround
Scottish vets get Lims upgrade
Scottish Agricultural College Veterinary Science Division laboratory upgrades from Dos- to Windows-based Lims, selecting newer version from same supplier
It uses novel algorithms to predict toxic end-points.
This approach to predictive toxicology offers a new perspective in this field.
This prediction techniques are complementary to well-established Qsar based-methods already used for decades.
Professor Peter Goldfarb, director of the university's centre for toxicology, commented: "We will be using ToxWiz because of its capability to accurately explore the rapidly expanding knowledge base deriving both from prior research in toxicology and from the current systems biology revolution.
"This will enable us to make earlier predictions about the safety of proposed new therapeutic agents and industrial chemicals.
"Additionally, ToxWiz is designed to predict the possible cellular mechanisms of any indicated toxicity and should help us plan our subsequent experimental work better.
"This would result in a significant reduction in the use of test animals (an objective to which Surrey has contributed for many years) and also make the testing of such chemicals in man even safer.
"CCnet is clearly focused on novel solutions to the challenges facing toxicologists today, not only in terms of developing safe new treatments for diseases such as diabetes and cancer, but also in responding to the EU requirement for the retesting of chemicals to which the public are exposed in their everyday lives".
Mariana Vaschetto, commercial director of Cambridge Cell Networks, commented: "Professor Goldfarb and his colleagues at the University of Surrey are leaders in the field of molecular toxicology and we are thrilled that they will be using ToxWiz to aid their research.
"We are sure that their feedback will be invaluable in helping us design the next generation of our system.
"With this contribution from an internationally-recognised academic group, we will be able to target the continuing development of ToxWiz on meeting the increasingly-rigorous needs of modern safety science".
Free trials of ToxWiz can be requested.
• Cambridge Cell Networks (CCnet): contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
